4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-23-125488
Chief Commercial Officer acquired 39,599 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lea Darrell Shane Chief Commercial Officer | 2023-12-08 | Grant or award | +39,599 | 39,599 | D | ||
| Derivatives | |||||||
| Lea Darrell Shane Chief Commercial Officer | 2023-06-23 | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X05/tm2332764-3_4seq1.xml…